Acne scars: new treatment

Published Date: 02 Mar 2023

Acne can ruin a person's life. What is the real evidence for an effective treatment for different types of acne scars?

Read Full News

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

How Anesthesiologists Predict Who Will Throw Up After Surgery

— And how we prevent it

Dexamethasone, Ondansetron Show No Difference After Cesarean

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish Experts Expand Care After Perinatal Loss

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Acetaminophen and Autism: Data, Debate, and Risk

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

Palliative Care Use in Hospitalized Hematologic Malignancies

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

Todays Updates

This Week on NeurologyLive® — September 28, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Somnolence Risk, Short-Term Efficacy Drive VMAT2 Inhibitor Choice in Older Adults With Tardive Dyskinesia Isabella Ciccone, MPH

In a discrete choice experiment, somnolence risk and short-term efficacy were the top factors driving vesicular monoamine transporter 2 inhibitor selection for tardive dyskinesia in patients aged 55 years and older.

FDA Approves Tavapadon for the Treatment of Parkinson Disease Isabella Ciccone, MPH

FDA approves once-daily oral tavapadon for Parkinson disease, a first-in-class D1/D5 partial agonist that improves motor function and ON time, with key safety warnings.

Gefurulimab Cuts Hospitalizations, Sustains Response in Phase 3 PREVAIL Trial of Myasthenia Gravis Marco Meglio

New PREVAIL trial analyses presented at the 2026 AANEM Annual Meeting showed gefurulimab reduced gMG-related hospitalizations and produced durable symptom and quality-of-life gains through one year.

SHIELD Trial Advances Combination Antiviral for Long COVID Marco Meglio

PridCor Therapeutics is moving its phase 2 SHIELD trial of a combination antiviral regimen toward enrollment, building on case series data showing durable symptom improvement in long COVID.

Inebilizumab Shows Durable Benefit in MuSK+ Generalized Myasthenia Gravis at AANEM 2026 Marco Meglio

New phase 3 MINT trial analyses presented at the 2026 AANEM Annual Meeting showed inebilizumab produced sustained improvement in MuSK-positive gMG regardless of time since diagnosis.

5 Nephrology Headlines You Missed in August 2026 Alex Hillenbrand

A joint ESC/ERA guideline on universal CKD screening headlines August 2026's nephrology news, alongside new finerenone and sibeprenlimab trial data.

Todays Updates

This Week on NeurologyLive® — September 28, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Somnolence Risk, Short-Term Efficacy Drive VMAT2 Inhibitor Choice in Older Adults With Tardive Dyskinesia Isabella Ciccone, MPH

In a discrete choice experiment, somnolence risk and short-term efficacy were the top factors driving vesicular monoamine transporter 2 inhibitor selection for tardive dyskinesia in patients aged 55 years and older.

FDA Approves Tavapadon for the Treatment of Parkinson Disease Isabella Ciccone, MPH

FDA approves once-daily oral tavapadon for Parkinson disease, a first-in-class D1/D5 partial agonist that improves motor function and ON time, with key safety warnings.

Gefurulimab Cuts Hospitalizations, Sustains Response in Phase 3 PREVAIL Trial of Myasthenia Gravis Marco Meglio

New PREVAIL trial analyses presented at the 2026 AANEM Annual Meeting showed gefurulimab reduced gMG-related hospitalizations and produced durable symptom and quality-of-life gains through one year.

SHIELD Trial Advances Combination Antiviral for Long COVID Marco Meglio

PridCor Therapeutics is moving its phase 2 SHIELD trial of a combination antiviral regimen toward enrollment, building on case series data showing durable symptom improvement in long COVID.

Inebilizumab Shows Durable Benefit in MuSK+ Generalized Myasthenia Gravis at AANEM 2026 Marco Meglio

New phase 3 MINT trial analyses presented at the 2026 AANEM Annual Meeting showed inebilizumab produced sustained improvement in MuSK-positive gMG regardless of time since diagnosis.

5 Nephrology Headlines You Missed in August 2026 Alex Hillenbrand

A joint ESC/ERA guideline on universal CKD screening headlines August 2026's nephrology news, alongside new finerenone and sibeprenlimab trial data.

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

— And how we prevent it

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

News All Time

Coma Therapy Tied to Poor Outcomes in Nonconvulsive SE

Patients with nonconvulsive status epilepticus treated with therapeutic coma experience markedly higher rates of complications and mortality than those not receiving the treatment.

Whole Person Approach to Pain Management for Vets in Hospice

This quality improvement project aims to support the uptake and utilization of nonpharmacological pain management interventions for veterans receiving inpatient hospice care.

Axial PsA Diagnosis: Applying AXIS Evidence in Practice

Dr Denis Poddubnyy discusses data from the AXIS study that inform his approach to diagnosing axial psoriatic arthritis.

Doc Sues Malpractice Insurer for Refusing to Settle Lawsuit

A South Carolina ob/gyn says MagMutual should have settled a patient’s malpractice lawsuit after a birth injury.

Cancer Pain Remains a Major Clinical Challenge

From nerve blocks to intrathecal systems, specialists say advanced pain strategies may help when standard analgesics fall short.

Outpatient Palliative Care Consult and End-of-Life Outcomes

This study evaluated the impact of outpatient palliative care consultation on Life-Sustaining Treatment note completion, hospice referral rates, and venue of death.

French Experts Say Medical Hypnosis May Ease ENT Procedures

Clinicians at a French hospital describe hypnosis as a complementary approach that may help patients in different age groups manage anxiety and pain during procedures.

Inpatient Palliative Care in Gynecological Malignancies

This study evaluated the national prevalence, trends, and inpatient outcomes of palliative care use among women hospitalized with gynecological malignancies.

Half of Veterans With Stage IV Cancer Die Without Hospice

Hospice care improves symptom control, reduces ICU utilization, and raises family-rated quality of dying among patients with advanced cancer.

Disposables Dominate Cesarean Anesthesia Carbon Footprint

Disposable items account for the majority of anesthesia-related carbon emissions during cesarean delivery, with a notable portion coming from products that are opened but discarded without use.

Trust Is Earned, Not Assumed

Trust flows both ways between physicians and their patients, says John Whyte, MD, MPH, CEO and executive vice president of the American Medical Association. Dr Whyte shares how he seeks to build that trust.

Hallucinogens: Overhyped and Underwhelming

Enthusiasm for hallucinogens has surged, but has the evidence kept pace? Dr Nassir Ghaemi examines the research behind ketamine, psilocybin, and MDMA — and argues for a more critical look.

Medicine Is a Team Sport

John Whyte, MD, MPH, CEO and executive vice president of the AMA, shares his advice for new physicians on how to build trust with their patients.

Poor Function Before ICU Admission Tied to Later Death Risk

Frailty and functional dependency before admission are associated with an increased risk for mortality after admission to the ICU, although the evidence remains uncertain.

Social Egg Freezing: Choice, Business, or Burden?

Growing interest in egg preservation raises questions about access, affordability, informed consent, and whether workplace pressures shift reproductive responsibility onto women.

Booming Weight-loss Drug Demand in Brazil Fuels Thriving Black Market and Health Fears

When Brazilian customs agents opened jars of dulce de leche aboard a tourist bus arriving from Paraguay in April, they discovered hundreds of vials of tirzepatide, the...

Recommended News For You

The Clues Hidden in Failed Prostate Cancer Trials

Study suggests exercise could reduce breast cancer recurrence

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

Studies point to redlining as a 'perfect storm' for breast cancer

Scholastic performance is a key concern for young cancer patients, study finds

Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer

Recommended Articles For You

Bone Marrow Niche Regeneration Strategies in Hematology 

Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges 

A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era 

Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Video: How to treat kidney disease?

2.

Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis

3.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

4.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

5.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

1.

Progressive Insights in Hematology in the Digital Era

2.

Organoid Models for Tumor Tissue Repair: Advances, Mechanisms, and Clinical Implications

3.

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access

4.

Longitudinal Monitoring in Hematologic Care Pathways

5.

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV

5.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot